WAM
SYRS

Wolverine Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Wolverine Asset Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-300
Closed -$26K – 1665
2020
Q3 		$26K Buy
+300
New +$26K ﹤0.01% 1068